Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 460

1.

The Neuroprotective Role of Protein Quality Control in Halting the Development of Alpha-Synuclein Pathology.

Manecka DL, Vanderperre B, Fon EA, Durcan TM.

Front Mol Neurosci. 2017 Sep 27;10:311. doi: 10.3389/fnmol.2017.00311. eCollection 2017. Review.

2.

Cerebral amyloid angiopathy-related cognitive impairment: The search for a specific neuropsychological pattern.

Planton M, Raposo N, Albucher JF, Pariente J.

Rev Neurol (Paris). 2017 Oct 6. pii: S0035-3787(17)30733-6. doi: 10.1016/j.neurol.2017.09.006. [Epub ahead of print] Review.

PMID:
28993004
3.

Diagnosis and Management of Cognitive and Behavioral Changes in Dementia With Lewy Bodies.

Tousi B.

Curr Treat Options Neurol. 2017 Oct 9;19(11):42. doi: 10.1007/s11940-017-0478-x. Review.

PMID:
28990131
4.

Therapeutic approaches to target alpha-synuclein pathology.

Brundin P, Dave KD, Kordower JH.

Exp Neurol. 2017 Oct 4. pii: S0014-4886(17)30245-5. doi: 10.1016/j.expneurol.2017.10.003. [Epub ahead of print] Review.

PMID:
28987463
5.

Current concepts and controversies in the pathogenesis of Parkinson's disease dementia and Dementia with Lewy Bodies.

Weil RS, Lashley TL, Bras J, Schrag AE, Schott JM.

F1000Res. 2017 Aug 30;6:1604. doi: 10.12688/f1000research.11725.1. eCollection 2017. Review.

6.

Mild cognitive impairment in Parkinson's disease: a distinct clinical entity?

Wen MC, Chan LL, Tan LCS, Tan EK.

Transl Neurodegener. 2017 Sep 13;6:24. doi: 10.1186/s40035-017-0094-4. eCollection 2017. Review.

7.

REM sleep behaviour disorder: not just a bad dream.

Matar E, Lewis SJ.

Med J Aust. 2017 Sep 18;207(6):262-268. Review.

PMID:
28899330
8.

Deconstructing normal pressure hydrocephalus: Ventriculomegaly as early sign of neurodegeneration.

Espay AJ, Da Prat GA, Dwivedi AK, Rodriguez-Porcel F, Vaughan JE, Rosso M, Devoto JL, Duker AP, Masellis M, Smith CD, Mandybur GT, Merola A, Lang AE.

Ann Neurol. 2017 Sep 11. doi: 10.1002/ana.25046. [Epub ahead of print] Review.

PMID:
28892572
9.

The Oligomer Hypothesis in α-Synucleinopathy.

Ono K.

Neurochem Res. 2017 Aug 21. doi: 10.1007/s11064-017-2382-x. [Epub ahead of print] Review.

PMID:
28828740
10.

Small-molecule PET Tracers for Imaging Proteinopathies.

Mathis CA, Lopresti BJ, Ikonomovic MD, Klunk WE.

Semin Nucl Med. 2017 Sep;47(5):553-575. doi: 10.1053/j.semnuclmed.2017.06.003. Epub 2017 Jul 13. Review.

PMID:
28826526
11.

Molecular Imaging and Updated Diagnostic Criteria in Lewy Body Dementias.

Bohnen NI, Müller MLTM, Frey KA.

Curr Neurol Neurosci Rep. 2017 Aug 14;17(10):73. doi: 10.1007/s11910-017-0789-z. Review.

PMID:
28808912
12.

Experimental animal models of Parkinson's disease: A transition from assessing symptomatology to α-synuclein targeted disease modification.

Ko WKD, Bezard E.

Exp Neurol. 2017 Jul 29. pii: S0014-4886(17)30202-9. doi: 10.1016/j.expneurol.2017.07.020. [Epub ahead of print] Review.

PMID:
28764902
13.

Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies.

Peng C, Gathagan RJ, Lee VM.

Neurobiol Dis. 2017 Jul 24. pii: S0969-9961(17)30170-5. doi: 10.1016/j.nbd.2017.07.018. [Epub ahead of print] Review.

PMID:
28751258
14.

New Therapeutic Strategies for Lewy Body Dementias.

Velayudhan L, Ffytche D, Ballard C, Aarsland D.

Curr Neurol Neurosci Rep. 2017 Sep;17(9):68. doi: 10.1007/s11910-017-0778-2. Review.

PMID:
28741230
15.

An update on the genetics of dementia with Lewy bodies.

Vergouw LJM, van Steenoven I, van de Berg WDJ, Teunissen CE, van Swieten JC, Bonifati V, Lemstra AW, de Jong FJ.

Parkinsonism Relat Disord. 2017 Jul 13. pii: S1353-8020(17)30256-0. doi: 10.1016/j.parkreldis.2017.07.009. [Epub ahead of print] Review.

PMID:
28734699
16.

The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma.

Ramirez AI, de Hoz R, Salobrar-Garcia E, Salazar JJ, Rojas B, Ajoy D, López-Cuenca I, Rojas P, Triviño A, Ramírez JM.

Front Aging Neurosci. 2017 Jul 6;9:214. doi: 10.3389/fnagi.2017.00214. eCollection 2017. Review.

17.

Structural and Functional Neuroimaging of Visual Hallucinations in Lewy Body Disease: A Systematic Literature Review.

Pezzoli S, Cagnin A, Bandmann O, Venneri A.

Brain Sci. 2017 Jul 15;7(7). pii: E84. doi: 10.3390/brainsci7070084. Review.

18.

A clinicopathological approach to the diagnosis of dementia.

Elahi FM, Miller BL.

Nat Rev Neurol. 2017 Aug;13(8):457-476. doi: 10.1038/nrneurol.2017.96. Epub 2017 Jul 14. Review.

PMID:
28708131
19.

α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease.

Singh SK, Dutta A, Modi G.

Future Med Chem. 2017 Jun;9(10):1039-1053. doi: 10.4155/fmc-2017-0016. Epub 2017 Jun 20. Review.

PMID:
28632413
20.

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O'Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K.

Neurology. 2017 Jul 4;89(1):88-100. doi: 10.1212/WNL.0000000000004058. Epub 2017 Jun 7. Review.

Supplemental Content

Loading ...
Support Center